BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9263738)

  • 1. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes.
    Hochberg Z; Aviram M; Rubin D; Pollack S
    Eur J Clin Invest; 1997 Jul; 27(7):543-7. PubMed ID: 9263738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I resistance and Turner's syndrome.
    Lebl J; Průhová S; Zapletalová J; Pechová M
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):37-41. PubMed ID: 11220703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation.
    Zadik Z; Landau H; Chen M; Altman Y; Lieberman E
    J Clin Endocrinol Metab; 1992 Aug; 75(2):412-6. PubMed ID: 1386373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
    Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture.
    Barreca A; Larizza D; Damonte G; Arvigo M; Ponzani P; Cesarone A; Lo Curto F; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1041-6. PubMed ID: 9100570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of growth hormone therapy on the developmental changes of follicle stimulating hormone and insulin-like growth factor-I serum concentrations in Turner's syndrome.
    Bourguignon JP; Gérard A; Deby-Dupont G; Franchimont P
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):85-9. PubMed ID: 8348710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome.
    Simmons KE
    Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
    Saggese G; Federico G; Cinquanta L
    Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile growth hormone release in Turner's syndrome and short normal children.
    Ghizzoni L; Lamborghini A; Ziveri M; Volta C; Panza C; Balestrazzi P; Bernasconi S
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):291-7. PubMed ID: 2239077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
    Reiter JC; Craen M; Van Vliet G
    Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous growth hormone secretion does not correlate with growth in patients with Turner's syndrome. Italian Study Group for Turner Syndrome.
    Cavallo L; Gurrado R
    J Pediatr Endocrinol Metab; 1999; 12(5):623-7. PubMed ID: 10703533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome?
    Vaccaro F; Cianfarani S; Pasquino AM; Boscherini B
    Metabolism; 1995 Aug; 44(8):1033-7. PubMed ID: 7637644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion in pubertal age patients with Turner's syndrome.
    Lanes R; Brito S; Suniaga M; Moncada G; Borges M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
    Veldhuis JD; Sotos JF; Sherman BM
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.